Acute Mesenteric Ischemia in COVID-19 Patients
Acute mesenteric ischemia is a rare but extremely severe complication of SARS-CoV-2 infection. The present review aims to document the clinical, laboratory, and imaging findings, management, and outcomes of acute intestinal ischemia in COVID-19 patients. A comprehensive search was performed on PubMed and Web of Science with the terms "COVID-19" and "bowel ischemia" OR "intestinal ischemia" OR "mesenteric ischemia" OR "mesenteric thrombosis". After duplication removal, a total of 36 articles were included, reporting data on a total of 89 patients, 63 being hospitalized at the moment of onset. Elevated D-dimers, leukocytosis, and C reactive protein (CRP) were present in most reported cases, and a contrast-enhanced CT exam confirms the vascular thromboembolism and offers important information about the bowel viability. There are distinct features of bowel ischemia in non-hospitalized vs. hospitalized COVID-19 patients, suggesting different pathological pathways. In ICU patients, the most frequently affected was the large bowel alone (56%) or in association with the small bowel (24%), with microvascular thrombosis. Surgery was necessary in 95.4% of cases. In the non-hospitalized group, the small bowel was involved in 80%, with splanchnic veins or arteries thromboembolism, and a favorable response to conservative anticoagulant therapy was reported in 38.4%. Mortality was 54.4% in the hospitalized group and 21.7% in the non-hospitalized group (p < 0.0001). Age over 60 years (p = 0.043) and the need for surgery (p = 0.019) were associated with the worst outcome. Understanding the mechanisms involved and risk factors may help adjust the thromboprophylaxis and fluid management in COVID-19 patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
---|---|
Enthalten in: |
Journal of clinical medicine - 11(2021), 1 vom: 30. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Serban, Dragos [VerfasserIn] |
---|
Links: |
---|
Themen: |
Acute mesenteric ischemia |
---|
Anmerkungen: |
Date Revised 14.01.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/jcm11010200 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM335470947 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM335470947 | ||
003 | DE-627 | ||
005 | 20231225225925.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/jcm11010200 |2 doi | |
028 | 5 | 2 | |a pubmed24n1118.xml |
035 | |a (DE-627)NLM335470947 | ||
035 | |a (NLM)35011941 | ||
035 | |a (PII)200 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Serban, Dragos |e verfasserin |4 aut | |
245 | 1 | 0 | |a Acute Mesenteric Ischemia in COVID-19 Patients |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 14.01.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Acute mesenteric ischemia is a rare but extremely severe complication of SARS-CoV-2 infection. The present review aims to document the clinical, laboratory, and imaging findings, management, and outcomes of acute intestinal ischemia in COVID-19 patients. A comprehensive search was performed on PubMed and Web of Science with the terms "COVID-19" and "bowel ischemia" OR "intestinal ischemia" OR "mesenteric ischemia" OR "mesenteric thrombosis". After duplication removal, a total of 36 articles were included, reporting data on a total of 89 patients, 63 being hospitalized at the moment of onset. Elevated D-dimers, leukocytosis, and C reactive protein (CRP) were present in most reported cases, and a contrast-enhanced CT exam confirms the vascular thromboembolism and offers important information about the bowel viability. There are distinct features of bowel ischemia in non-hospitalized vs. hospitalized COVID-19 patients, suggesting different pathological pathways. In ICU patients, the most frequently affected was the large bowel alone (56%) or in association with the small bowel (24%), with microvascular thrombosis. Surgery was necessary in 95.4% of cases. In the non-hospitalized group, the small bowel was involved in 80%, with splanchnic veins or arteries thromboembolism, and a favorable response to conservative anticoagulant therapy was reported in 38.4%. Mortality was 54.4% in the hospitalized group and 21.7% in the non-hospitalized group (p < 0.0001). Age over 60 years (p = 0.043) and the need for surgery (p = 0.019) were associated with the worst outcome. Understanding the mechanisms involved and risk factors may help adjust the thromboprophylaxis and fluid management in COVID-19 patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a acute mesenteric ischemia | |
650 | 4 | |a cytokines | |
650 | 4 | |a endothelitis | |
650 | 4 | |a hypercoagulability | |
650 | 4 | |a thromboemboembolism | |
700 | 1 | |a Tribus, Laura Carina |e verfasserin |4 aut | |
700 | 1 | |a Vancea, Geta |e verfasserin |4 aut | |
700 | 1 | |a Stoian, Anca Pantea |e verfasserin |4 aut | |
700 | 1 | |a Dascalu, Ana Maria |e verfasserin |4 aut | |
700 | 1 | |a Suceveanu, Andra Iulia |e verfasserin |4 aut | |
700 | 1 | |a Tanasescu, Ciprian |e verfasserin |4 aut | |
700 | 1 | |a Costea, Andreea Cristina |e verfasserin |4 aut | |
700 | 1 | |a Tudosie, Mihail Silviu |e verfasserin |4 aut | |
700 | 1 | |a Tudor, Corneliu |e verfasserin |4 aut | |
700 | 1 | |a Gangura, Gabriel Andrei |e verfasserin |4 aut | |
700 | 1 | |a Duta, Lucian |e verfasserin |4 aut | |
700 | 1 | |a Costea, Daniel Ovidiu |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical medicine |d 2012 |g 11(2021), 1 vom: 30. Dez. |w (DE-627)NLM230666310 |x 2077-0383 |7 nnns |
773 | 1 | 8 | |g volume:11 |g year:2021 |g number:1 |g day:30 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/jcm11010200 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 11 |j 2021 |e 1 |b 30 |c 12 |